市场调查报告书
商品编码
1518566
2024-2032 年麻醉二氧化碳吸收剂市场报告(按产品(钠石灰、Medisorb、Dragersorb、Amsorb、Litholyme 等)、类型(高级、传统)、最终用户(医院、诊所等)和地区Anesthesia CO2 Absorbent Market Report by Product (Soda Lime, Medisorb, Dragersorb, Amsorb, Litholyme, and Others), Type (Premium, Traditional), End User (Hospitals, Clinics, and Others), and Region 2024-2032 |
IMARC Group年,全球麻醉二氧化碳吸收剂市场规模达到7,850万美元。
麻醉二氧化碳吸收剂是麻醉一次性用品中的一个特殊部分,主要用于吸收麻醉过程中呼出的气体。这些吸收剂配方由强氢氧化钾和氢氧化钠碱组成,有助于将麻醉分子中的不稳定质子转化为一氧化碳 (CO),有助于最大限度地减少麻醉废物。由麻醉吸收剂组成的二氧化碳吸收装置被併入麻醉机的呼吸装置中,位于环形迴路的吸气肢和呼气肢之间。它们的功能是将新鲜气体的流量限制在闭路条件下,并允许呼出的麻醉剂被重新吸入。然而,一氧化碳(CO)的产生会对患者的健康造成危害。某些二氧化碳吸收剂不含氢氧化钾和氢氧化钠,因此不会透过与吸入剂反应产生一氧化碳。
这个市场主要是由心臟病、神经系统疾病、呼吸系统疾病和糖尿病等慢性病发病率上升所推动的。同时,越来越多的老年人口容易患上最终需要手术干预的疾病,这为市场提供了巨大的推动力。除此之外,随着众多医疗机构进行的手术数量不断增加,对麻醉一次性用品的需求大幅增加,从而促进了产品在全球的采用。有关整个医疗保健行业麻醉药品和设备使用的各种严格的政府指南和安全参数进一步推动了产品需求。除此之外,用于开发先进二氧化碳吸收配方的研发(R&D)活动的投资不断增加以及医疗保健支出的不断增加也推动了市场成长。
The global anesthesia CO2 absorbent market size reached US$ 78.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 129.0 Million by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032.
Anesthesia CO2 absorbent is a specific segment within the anesthesia disposables, which is primarily used to absorb exhaled gases during anesthesia administration. Consisting of strong potassium hydroxide and sodium hydroxide bases that help obtain labile protons from anesthetic molecules to carbon monoxide (CO), these absorbent formulations are instrumental in minimizing anesthetic wastes. The CO2 absorber devices consisting of anesthesia absorbents are incorporated into the ventilatory apparatus of the anesthesia machine between the inspiratory and expiratory limbs of a circle circuit. They function by limiting the flow of fresh gas to closed-circuit conditions and allowing exhaled anesthetic agents to be rebreathed. However, the production of carbon monoxide (CO) can cause health hazards to patients. Certain CO2 absorbents do not contain potassium hydroxide, and sodium hydroxide and consequently do not produce carbon monoxide by reacting with inhaled agents.
The market is primarily driven by the rising incidences of chronic conditions, such as cardiac disorders, neurological conditions, respiratory diseases, and diabetes. Along with this, the growing geriatric population that is susceptible to developing medical conditions ultimately requiring surgical intervention is providing a significant boost to the market. Besides this, with the rising number of surgeries conducted across numerous healthcare settings, there has been a considerable rise in the demand for anesthesia disposables, thereby contributing to the product adoption across the globe. Various stringent government guidelines and safety parameters regarding the usage of anesthetic drugs and equipment across the healthcare sector are further propelling the product demand. In addition to this, the increasing investments in the research and development (R&D) activities for developing advanced CO2 absorbing formulations and the expanding healthcare expenditure are also providing an impetus to the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global anesthesia CO2 absorbent market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, type and end user.
Soda Lime
Medisorb
Dragersorb
Amsorb
Litholyme
Others
Premium
Traditional
Hospitals
Clinics
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Armstrong Medical Ltd. (Eakin Healthcare Group Ltd), Atrasorb, Dragerwerk AG & Co. KGaA, General Electric Company, Intersurgical Ltd., Lowenstein Medical SE & Co. KG, Micropore Inc., Molecular Products Group plc (Filtration Group Corporation) and Smiths Medical Inc. (ICU Medical Inc.).